MedPage Today (8/28, Robertson) reports, “For mothers with opioid use disorder (OUD), the use of medication for their addiction such as buprenorphine or methadone during the prenatal period was associated with improved outcomes in infants,” investigators concluded in findings published online in JAMA Pediatrics. Utilizing “data from a multistate Medicaid database on over 10,000 mother-infant dyads, prenatal use of medications for OUD was found to be associated with 20% higher odds of infants receiving six well-child visits…and 20% lower odds of readmissions” during “the first year of life,” the study found.
Related Links:
— MedPage Today (requires login and subscription)